Companies / Virginia / Retension Pharmaceuticals

· rebuilt nightly from public records

Signal Sheet

Selling to Retension Pharmaceuticals? Who to reach and why now

Headquartered in Mclean, Virginia, Retension Pharmaceuticals is a publicly listed pharmaceutical preparations company, founded 2023. It raised $12.3M in Apr 2025 and its filings name 3 officers. Everything below links to the record it came from.

Listed company · Pharmaceutical Preparations · Virginia

The easy button for new customers

Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.

Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.

SourceNew accounts that match what you offer, added as the signals land. The list never runs dry.
Reach outA first email written from why the account is hot, then a drip sequence that follows up until they reply. Sent from your own mailbox, with every open and reply tracked.
PursueAn AI-written plan built from your value proposition and the customer's compelling event: who to call, what to lead with, and the next step to win it. In early access.
Start your free trial →Tell it what you sell and where. Your list stays yours.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerEric KellerSEC filing, Apr 2025Named officer in the filing; part of the buying group
Chief Technology OfficerMichael BerendtSEC filing, Apr 2025Technology and tooling decisions
Chief Technology OfficerDonald OldsSEC filing, Apr 2025Technology and tooling decisions
Chief Executive OfficerFind with a free trialLakewave contact searchSigns off on new vendors; budget owner
Chief Financial OfficerFind with a free trialLakewave contact searchApproves spend after a raise
Chief Information OfficerFind with a free trialLakewave contact searchOwns IT and infrastructure vendors
For sellersWhy Retension Pharmaceuticals is worth a call this quarterBuy Window: open · new leadership Oct 2026
Oct 21Oct 2026

New leadership

Officer or director change

New leadership
Sep 2026Sep 2026

Capital

Filed to go public

Capital
3officers

Named in filings

Each with a title and the filing that names them, so the first call goes to the right desk.

People
Track Retension Pharmaceuticals with a free trial →Get the next signal the day it is filed or posted.
Email me the next Retension Pharmaceuticals signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Oct 21, 2026Officer or director changeNew leadershipSEC filing
Sep 18, 2026Filed to go publicCapitalSEC filing
Apr 22, 2025Raised $12.3M in equity from 98 investorsCapitalSEC filing

Reach Retension Pharmaceuticals with emails that land

Lakewave finds the right people at Retension Pharmaceuticals, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on Retension Pharmaceuticals with a free trial →

About Retension Pharmaceuticals

HeadquartersMclean, Virginia, per the filing address
Industry groupPharmaceutical Preparations
Founded2023, DE
OwnershipListed company
Raise history$12.3M (Apr 2025)
Lakewave Rising50 · 2 kinds of evidence · rank in Virginia after sign-up

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Quoin Pharmaceuticals · 29

Questions people ask

Did Retension Pharmaceuticals raise funding in 2025?

Yes. Retension Pharmaceuticals reported a $12.3M equity raise to the SEC on Apr 22, 2025 with 98 investors.

Who runs Retension Pharmaceuticals?

The company's SEC filing, Apr 2025 names Eric Keller (Executive Officer) among its officers.

Where is Retension Pharmaceuticals headquartered?

Mclean, Virginia, per the address on its SEC filing.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.